Moleculin Biotech Inc
NASDAQ:MBRX
Moleculin Biotech Inc
Cash from Investing Activities
Moleculin Biotech Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Moleculin Biotech Inc
NASDAQ:MBRX
|
Cash from Investing Activities
-$124k
|
CAGR 3-Years
31%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Investing Activities
-$2B
|
CAGR 3-Years
62%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-76%
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Investing Activities
-$26.2B
|
CAGR 3-Years
-69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
-50%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Investing Activities
-$3.2B
|
CAGR 3-Years
-256%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-25%
|
See Also
What is Moleculin Biotech Inc's Cash from Investing Activities?
Cash from Investing Activities
-124k
USD
Based on the financial report for Dec 31, 2023, Moleculin Biotech Inc's Cash from Investing Activities amounts to -124k USD.
What is Moleculin Biotech Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
22%
Over the last year, the Cash from Investing Activities growth was -77%. The average annual Cash from Investing Activities growth rates for Moleculin Biotech Inc have been 31% over the past three years , 22% over the past five years .